1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Sex-Differences in Alpha-1 Antitrypsin Deficiency : Data From the EARCO Registry
(
- Contribution to journal › Article
- 2024
-
Mark
Risk of lung disease in the PI*SS genotype of alpha-1 antitrypsin : an EARCO research project
(
- Contribution to journal › Article
- 2023
-
Mark
Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries : EARCO international registry
(
- Contribution to journal › Letter
- 2022
-
Mark
Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency : The IMCA1 Study of the EARCO Clinical Research Collaboration
(
- Contribution to journal › Letter
-
Mark
Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency : EARCO international registry
(
- Contribution to journal › Article
- 2021
-
Mark
Research priorities to address the global burden of chronic obstructive pulmonary disease (COPD) in the next decade
(
- Contribution to journal › Article
- 2019
-
Mark
Prevalence and characteristics of asthma-chronic obstructive pulmonary disease overlap in routine primary care practices
(
- Contribution to journal › Article
- 2018
-
Mark
Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK
(
- Contribution to journal › Article
-
Mark
Chronic obstructive pulmonary disease guidelines in Europe : A look into the future
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Gene and miRNA expression profiles in PBMCs from patients with severe and mild emphysema and PiZZ alpha I-antitrypsin deficiency
(
- Contribution to journal › Article